<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="120822">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01654471</url>
  </required_header>
  <id_info>
    <org_study_id>WIQ-SNU</org_study_id>
    <nct_id>NCT01654471</nct_id>
  </id_info>
  <brief_title>Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial Disease</brief_title>
  <official_title>Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Astellas Pharma Korea, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to validate the Korean version of Walking Impairment Questionnaire
      in patients with peripheral arterial occlusive disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      First, the original version of WIQ will be translated into Korean, then it will be
      translated into English, again. The translated version will be sent to the original author
      to compare with the original version. After correcting, the Korean version will be
      completed.

      The patients with peripheral arterial disease will fill in the Korean version of WIQ before
      starting treatments. Baseline results of arterial function test, toe-brachial index and
      treadmill test will be recorded. Three months later, the patients will complete the
      questionnaire again. Arterial function test, toe-brachial index and treadmill test also will
      be taken again after treatment and the correlation of WIQ and other exams will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Peripheral Arterial Occlusive Disease</condition>
  <arm_group>
    <arm_group_label>Medical treatment</arm_group_label>
    <description>only medical treatment (regardless of the kinds of medicine)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgical or endovascular treatemnt group</arm_group_label>
    <description>patients underwent surgery or endovascular therapy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with peripheral arterial disease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  19~ 80 years

          -  claudication

          -  Ankle brachial index &lt; 0.9 or TBI &lt; 0.7 (in patients with DM and ABI higher than 1.3)

          -  patients who can complete the treadmill test (slope 12%, 2.4km/hr)

        Exclusion Criteria:

          -  critical limb ischemia

          -  Ankle pressure &lt; 40mmHg

          -  claudication due to other causes (i.e. spinal stenosis, arthritis, etc)

          -  patients with high risk of coronary artery syndrome during treadmill test
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Seung-Kee Min, M.D.,PhD</last_name>
    <phone>82-2-2072-2817</phone>
    <email>docmin88@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seung-Kee Min, M.D.,PhD</last_name>
      <phone>82-2-2072-0297</phone>
      <email>docmin88@snu.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 11, 2013</lastchanged_date>
  <firstreceived_date>July 27, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Seung-Kee Min</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Walking Impairment Questionnaire</keyword>
  <keyword>Peripheral arterial occlusive disease</keyword>
  <keyword>Korean version</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
